D. Armangil Et Al. , "Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4, pp.352-357, 2011
Armangil, D. Et Al. 2011. Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4 , 352-357.
Armangil, D., YURDAKÖK, M., OKUR, H., & Gurgey, A., (2011). Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4, 352-357.
Armangil, Didem Et Al. "Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4, 352-357, 2011
Armangil, Didem Et Al. "Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4, pp.352-357, 2011
Armangil, D. Et Al. (2011) . "Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.4, pp.352-357.
@article{article, author={Didem Armangil Et Al. }, title={Plasminogen Activator Inhibitor 1 4G/5G Polymorphism in Neonatal Respiratory Distress Syndrome}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2011, pages={352-357} }